National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao

Page 1 <img data-url='document/national-library-of-dolasetron-najnoviji-5-ht3-antagonista-ispiti-van-u-tretmanu.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022050204/5f5757d806e75d07ef6ddce3/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/national-library-of-dolasetron-najnoviji-5-ht3-antagonista-ispiti-van-u-tretmanu.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022050204/5f5757d806e75d07ef6ddce3/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/national-library-of-dolasetron-najnoviji-5-ht3-antagonista-ispiti-van-u-tretmanu.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022050204/5f5757d806e75d07ef6ddce3/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/national-library-of-dolasetron-najnoviji-5-ht3-antagonista-ispiti-van-u-tretmanu.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022050204/5f5757d806e75d07ef6ddce3/html5/thumbnails/4.jpg' width='140' height='200' /> Page 5 <img data-url='document/national-library-of-dolasetron-najnoviji-5-ht3-antagonista-ispiti-van-u-tretmanu.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022050204/5f5757d806e75d07ef6ddce3/html5/thumbnails/5.jpg' width='140' height='200' />

National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV. Brzo sc konver- tuje u metabolit hydrodolasetron, koji se pokazao

Documents